<DOC>
	<DOCNO>NCT03095001</DOCNO>
	<brief_summary>Background : Malignant peritoneal adhesion common complication prognostic factor ovarian cancer primary abdominal tumor . The incidence peritoneal adhesion advance primary peritoneal tumor 32-56 % , increase 10 time recent decade . Malignant peritoneal adhesion closely associate morbidity mortality malignant intestinal obstruction . The peritoneal adhesion may aggravate abdominal symptom reduce quality life . Further , peritoneal adhesion may impede treatment primary tumor , operation chemotherapy , lead poor prognosis . Objective : This study aim treat malignant peritoneal adhesion combination antiangiogenic agent chemotherapy , evaluate efficacy safety intraperitoneal antiangiogenic agent plus chemotherapy . As explosive endpoint , examination expression VEGF-A peritoneal cavity treatment .</brief_summary>
	<brief_title>Intraperitoneal Chemotherapy Alone Combination With Bevacizumab Ovarian Cancer With Peritoneal Adhesion</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>1 . Pathologically radiologically confirm stage IV postoperative recurrence ovarian cancer . 2 . Age 1870 , Karnofsky score high 80 . 3 . No severe functional damage major organ , normal liver kidney function . 4 . Peritoneal adhesion . ( 1 ) peritoneal adhesion diagnose microlaparoscopy abdominal operation , classification accord Nair criterion perform . ( 1 ) must meet . ( 2 ) Peritoneal adhesion symptom , intermittent abdominal pain , abdominal distension , nausea vomiting , hard pas stool gas ; ( 3 ) Peritoneal adhesion signsï¼Œabdominal distension , abdominal tenderness , reduce absent bowel sound ; ( 4 ) B ultrasound CT MRI show peritoneal adhesion adhesionrelated complication . 1 . Complete intestinal obstruction suitable surgery . 2 . Patients know allergic bevacizumab component drug . 3 . Other ongoing antitumor treatment . 4 . Heart disease significant clinical symptom , : congestive heart failure , coronary heart disease symptom , arrhythmia hardly control drug , myocardial infarction 6 month , heart failure 5 . Active wound infection history uncontrolled psychiatric illness .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>bevacizumab</keyword>
	<keyword>Intraperitoneal administration</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Peritoneal Adhesion</keyword>
</DOC>